Error loading player: No playable sources found

AM24-MN-34-O

AM24-MN-34-O: Mechanisms and Technologies Towards Expanding Hematopoietic Stem Cells for Transplantation (Enduring)

Date
October 23, 2024
Credits
1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP)
$30
Standard Price
Members save $5
This product is also available as part of the following products:
Thumbnail for 2024 AABB Annual Meeting On-Demand: BIOTHERAPIES SESSIONS
Interested in all sessions Cellular Therapy/Biotherapies? Then this is the package for you. We have also thrown in a couple of additional sessions you might also find interesting…
Thumbnail for 2024 AABB Annual Meeting On-Demand: CABP CE Eligible Sessions
Interested in sessions eligible to maintain your AABB Certified Advanced Biotherapies Professional (CABP) certification? This package provides:
Thumbnail for 2024 Annual Meeting On-Demand: FULL ACCESS
By far the best value to watch all the on-demand educational sessions from the 2024 AABB Annual Meeting and earn continuing education credit…

CABP CE Eligible

Hematopoietic stem cells (HSCs) are the apex hematopoietic cell with the potential to produce robust and lifelong production of all blood cells. Thus, understanding the details of HSC molecular biology is critical to our understanding of human health and longevity. Mechanistic insights into HSC biology could be leveraged to further improve the strategies available to maintain and expand functional HSCs in vitro. Overcoming these hurdles is critical to effectively use HSCs for off-the-shelf allogeneic HSC transplantation or gene-editing of autologous HSCs for treatments of hematological disease and malignancies. In this session, we will discuss the most recent applications of HSC expansion technology currently in clinical use. We will also explore the latest mechanistic breakthroughs towards producing abundant HSCs in vitro for use in transfusion applications.

Learning Objectives

  • Uncover latest mechanistic underpinnings of hematopoietic stem cell (HSC) cycling and maintenance of stem cell self-renewal in vitro.
  • Define the molecular mechanisms and that contribute to exhaustion of HSCs under tissue culture conditions.
  • Describe the latest advances in technologies and methods to expand functional HSCs and de novo generation of HSCs in vitro.

Moderator

Speaker Image for Larry Luchsinger
New York Blood Center

Speakers

Speaker Image for Adam Wilkinson
Associate Professor Of Stem Cell Biology, University of Oxford

Related Products

Thumbnail for AM24-MN-26-O: Overview of Cell-Based Biologics Manufacturing as a Contracted Service (Enduring)
AM24-MN-26-O: Overview of Cell-Based Biologics Manufacturing as a Contracted Service (Enduring)
Decentralized manufacturing has become a prominent focus in the Advanced Therapies space as the number of therapies in development increases and patient volumes surge with earlier line treatment objectives…
Thumbnail for AM24-TU-10-O: Is Your Firm Ready for an FDA Office of Inspections and Investigations Inspection?  Hear about the Most Frequently Cited Observations and Inspectional Process from FDA’s Office of Biologics Inspectorate (Enduring)
AM24-TU-10-O: Is Your Firm Ready for an FDA Office of Inspections and Investigations Inspection? Hear about the Most Frequently Cited Observations and Inspectional Process from FDA’s Office of Biologics Inspectorate (Enduring)
This informative session will give an overview of inspections conducted by FDA’s Office of Inspections and Investigations (OII), Office of Biologics Inspectorate (OBI), including OBI’s role in regulatory inspections and current regulatory oversight…
Thumbnail for AM24-TU-03-O: Addressing Racial Disparities Across Donation Products for Marginalized Peoples (Enduring)
AM24-TU-03-O: Addressing Racial Disparities Across Donation Products for Marginalized Peoples (Enduring)
Despite the need for diverse donors of blood, stem cells, and organs/tissues, such donors remain dramatically underrepresented in donor pools, across donation products.. This session will begin with a brief didactic component, where expert presenters (Dr…
Thumbnail for AM24-MN-31-O: Cell Therapy: Creative Inventory Management & Discard (Enduring)
AM24-MN-31-O: Cell Therapy: Creative Inventory Management & Discard (Enduring)
A presentation of how one facility tackled a massive inventory reduction project to discard cell therapy products that had been in LN2 storage for 10 to 25 years…